A novel application perspective of the clinical-used drug verapamil on osteoporosis via targeting Txnip

A novel application perspective of the clinical-used drug verapamil on osteoporosis via targeting Txnip

Background: RANKL and SCLEROSTIN antibodies have provided a strong effective choice for treating osteoporosis in the past years, which suggested novel molecular target identification and therapeutic strategies development are important for the treatment of osteoporosis. The therapeutic effect of ver...

Full description

Bibliographic Details
Main Authors: Xiankun Cao, Kewei Rong, Yinghua Li, Pu Zhang, Kexin Liu, Lei Cui, Shaotian Fu, Qi Hua, Xiao Yang, Hang Zhang, Xiaofei Cheng, Peixiang Ma, Jie Zhao, An Qin
Format: Article
Language:English
Published: Elsevier 2025-01-01
Series:Journal of Orthopaedic Translation
Subjects:
Bone turnover
ChREBP
Osteoporosis
Txnip
Verapamil
Online Access:http://www.sciencedirect.com/science/article/pii/S2214031X24001360

Internet

http://www.sciencedirect.com/science/article/pii/S2214031X24001360

Similar Items